Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

The ferroportin Q248H mutation protects from anemia, but not malaria or bacteremia

Open access

Abstract

growth in Q248H erythrocytes ex vivo, nor evidence of selection driven by malaria exposure, suggesting that the Q248H mutation does not protect from malaria and is unlikely to deprive malaria parasites of iron essential for their growth.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/sciadv.aaw0109

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Collections with biological samples and phenotype and genetic data available in humans to test associations between anemia, iron, malaria, and bacteremia traits and the FPN Q248H mutation. (A) Proportion of total individuals with samples and data available for iron-related traits, and the Q248H mutation are shown in a heatmap of green gradient, representing the proportion of individuals with biological samples available, stratified by population with longitude and latitude represented on a map of the African continent. (B) Individuals with genetic data available from the 1000 Genomes Phase 3 Project with sequence data available stratified by population with longitude and latitude represented on a map of the African continent. MCV, mean cell volume; sTFR, soluble transferrin receptor; ZPP, zinc protoporphyrin; CRP, C-reactive protein; erythrocyte* includes samples available for ex vivo Plasmodium growth assay.
Fig. 1 Collections with biological samples and phenotype and genetic data available in humans to test associations between anemia, iron, malaria, and bacteremia traits and the FPN Q248H mutation. (A) Proportion of total individuals with samples and data available for iron-related traits, and the Q248H mutation are shown in a heatmap of green gradient, representing the proportion of individuals with biological samples available, stratified by population with longitude and latitude represented on a map of the African continent. (B) Individuals with genetic data available from the 1000 Genomes Phase 3 Project with sequence data available stratified by population with longitude and latitude represented on a map of the African continent. MCV, mean cell volume; sTFR, soluble transferrin receptor; ZPP, zinc protoporphyrin; CRP, C-reactive protein; erythrocyte* includes samples available for ex vivo Plasmodium growth assay.CC BY · PubMed Central
Fig. 2 FPN Q248H mutation is associated with protection from anemia, red cell hemolysis, and iron deficiency. The Q248H mutation renders FPN partially resistant to hepcidin degradation (4), increasing iron export through enterocytes, erythrocytes, and macrophages. The effects of Q248H on (A) anemia, (B) hemoglobin, (C) MCHC, (D) haptoglobin, (E) iron deficiency, (F) transferrin saturation (TSAT), (G) hepcidin, (H) ferritin, (I) soluble transferrin receptors (sTfR), (J) ZPP, and (K) inflammation indicate reduced hemolysis, limited effect on iron status, and no association with inflammation. Plotted values are geometric means except anemia, iron deficiency, and inflammation, which are percentages. All P values were two tailed and derived from regression models adjusted for age, sex, and cohort. GIT, gastrointestinal tract; DMT1, divalent metal transporter 1.
Fig. 2 FPN Q248H mutation is associated with protection from anemia, red cell hemolysis, and iron deficiency. The Q248H mutation renders FPN partially resistant to hepcidin degradation (4), increasing iron export through enterocytes, erythrocytes, and macrophages. The effects of Q248H on (A) anemia, (B) hemoglobin, (C) MCHC, (D) haptoglobin, (E) iron deficiency, (F) transferrin saturation (TSAT), (G) hepcidin, (H) ferritin, (I) soluble transferrin receptors (sTfR), (J) ZPP, and (K) inflammation indicate reduced hemolysis, limited effect on iron status, and no association with inflammation. Plotted values are geometric means except anemia, iron deficiency, and inflammation, which are percentages. All P values were two tailed and derived from regression models adjusted for age, sex, and cohort. GIT, gastrointestinal tract; DMT1, divalent metal transporter 1.CC BY · PubMed Central
Fig. 3 Effect of FPN Q248H variant on parasite P. falciparum growth rates and parasite density. (A) Ex vivo parasite growth rates in fresh erythrocytes from Gambian children (6 to 29 months) and mid-pregnant women stratified by carriage of Q248H FPN mutation (Het, heterozygous; Hom, homozygous). Parasite growth rates are geometric means from log-transformed data from triplicate assays. See the Materials and Methods for details of the assays and the clinical trials from which the samples were derived. A total of 229 genotyped children contributed data on up to three visits each (days 0, 49, and 84 of iron supplementation) and 380 genotyped pregnant women contributed data on up to four visits each (days 0, 14, 49, and 84). P values were calculated by analysis of variance (ANOVA) with visit day as a covariate to allow for supplementation effect. There was no interaction with hemoglobin or anemia or with plasma hepcidin (as a continuous variable or as above or below the thresholds of 5.5 ng/ml in children and 2.5 ng/ml in pregnant women). In the combined analysis of women and children, there was no interaction with study, confirming that merging of the datasets was legitimate. (B) P. falciparum parasite densities in hospitalized Kenyan children with severe malaria stratified by carriage of Q248H. Parasite densities are geometric means from log-transformed data. N, severe malaria cases. P values were derived from regression models adjusted for age, sex, and cohort. *Q248H heterozygotes and homozygotes combined (n = 3 homozygotes).
Fig. 3 Effect of FPN Q248H variant on parasite P. falciparum growth rates and parasite density. (A) Ex vivo parasite growth rates in fresh erythrocytes from Gambian children (6 to 29 months) and mid-pregnant women stratified by carriage of Q248H FPN mutation (Het, heterozygous; Hom, homozygous). Parasite growth rates are geometric means from log-transformed data from triplicate assays. See the Materials and Methods for details of the assays and the clinical trials from which the samples were derived. A total of 229 genotyped children contributed data on up to three visits each (days 0, 49, and 84 of iron supplementation) and 380 genotyped pregnant women contributed data on up to four visits each (days 0, 14, 49, and 84). P values were calculated by analysis of variance (ANOVA) with visit day as a covariate to allow for supplementation effect. There was no interaction with hemoglobin or anemia or with plasma hepcidin (as a continuous variable or as above or below the thresholds of 5.5 ng/ml in children and 2.5 ng/ml in pregnant women). In the combined analysis of women and children, there was no interaction with study, confirming that merging of the datasets was legitimate. (B) P. falciparum parasite densities in hospitalized Kenyan children with severe malaria stratified by carriage of Q248H. Parasite densities are geometric means from log-transformed data. N, severe malaria cases. P values were derived from regression models adjusted for age, sex, and cohort. *Q248H heterozygotes and homozygotes combined (n = 3 homozygotes).CC BY · PubMed Central
Fig. 4 Frequencies of adenine allele of rs11568350 encoding the Q248H mutation in African populations compared with the composite maximal estimate of P. falciparum transmission in 2- to 10-year-olds between the years 1900 and 1959. Regional median estimates of transmission are provided across malaria endemic regions of the natural extent of sub-Saharan Africa including the Island of Madagascar as obtained from Snow et al. (14). Population-specific frequencies of the variant encoding the Q248H allele are shown as pie charts for each of the included populations with the more common ancestral allele colored in black and the rarer adenine allele colored. For illustration purposes, colors are assigned on a scale matched to the P. falciparum parasite prevalence scale using a frequency of 10% as equivalent to a prevalence of 1 (for example, green represents 5% allele frequency). If there were a correlation between the allele frequencies and malaria prevalence, one would expect to see similar colors in the pie chart slices and map contours. The allele frequencies and estimated maximal estimates of transmission per population are plotted against each other in fig. S4.
Fig. 4 Frequencies of adenine allele of rs11568350 encoding the Q248H mutation in African populations compared with the composite maximal estimate of P. falciparum transmission in 2- to 10-year-olds between the years 1900 and 1959. Regional median estimates of transmission are provided across malaria endemic regions of the natural extent of sub-Saharan Africa including the Island of Madagascar as obtained from Snow et al. (14). Population-specific frequencies of the variant encoding the Q248H allele are shown as pie charts for each of the included populations with the more common ancestral allele colored in black and the rarer adenine allele colored. For illustration purposes, colors are assigned on a scale matched to the P. falciparum parasite prevalence scale using a frequency of 10% as equivalent to a prevalence of 1 (for example, green represents 5% allele frequency). If there were a correlation between the allele frequencies and malaria prevalence, one would expect to see similar colors in the pie chart slices and map contours. The allele frequencies and estimated maximal estimates of transmission per population are plotted against each other in fig. S4.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Cited by

See all 30

Metadata

Authors
Muriuki, J. M., Mentzer, A. J., Band, G., Gilchrist, J. J., Carstensen, T., Lule, S. A., Goheen, M. M., Joof, F., Kimita, W., Mogire, R., Cutland, C. L., Diarra, A., Rautanen, A., Pomilla, C., Gurdasani, D., Rockett, K., Mturi, N., Ndungu, F. M., Scott, J. A. G., Sirima, S. B., Morovat, A., Prentice, A. M., Madhi, S. A., Webb, E. L., Elliott, A. M., Bejon, P., Sandhu, M. S., Hill, A. V. S., Kwiatkowski, D. P., Williams, T. N., Cerami, C., & Atkinson, S. H.
Affiliations
  • Kenya Medical Research Institute (KE)
  • Centre for Human Genetics (GB)
  • Wellcome Sanger Institute (GB)
  • London School of Hygiene & Tropical Medicine (GB)
  • University of North Carolina at Chapel Hill (US)
  • MRC Unit the Gambia (GM)
  • University of the Witwatersrand (ZA)
  • Centre de Recherche Action en Sante (GRAS), 06 BP 10248, Ouagadougou 06, Burkina Faso.
  • University of Oxford (GB)
Corresponding author
  • Mentzer, Alexander J.
  • Atkinson, Sarah H.
Venue
Science Advances
Published
2019-09-06
Volume
5
Issue
9
Pages
eaaw0109-eaaw0109
ISSN
2375-2548 (ISSN-L)
OpenAlex
W2971983526
Cited by
29
References
38
Citations by year
2026: 3 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 3 · 2021: 8 · 2020: 6 · 2019: 1
FWCI
3.18
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Science Advances (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Spiral (Imperial College London) (submittedVersion, other-oa)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Apollo (cc-by)
Funders
  • National Institute of Child Health and Human Development
  • Bill and Melinda Gates Foundation
  • Wellcome Trust (110255/Z/15/Z, 202800/Z/16/Z, 106289/Z/14/Z, 064693, 079110, 095778, 203077/Z/16/Z, 090532/Z/09/Z, 203141, 098051, 206194)
  • Wellcome (107769/Z/10/Z, 107743/Z/15/Z, WT077383/Z/05/Z, 090770/Z/09/Z, 204911/Z/16/Z, 084716/Z/08/Z, 085475/B/08/Z, 085475/Z/08/Z)
  • Medical Research Council (G0600718, G0600230, MR/M006212/1, MC-A760-5QX00)
  • Department for International Development, UK Government
  • New Partnership for Africa’s Development (DEL-15-003)
  • National Institute for Health Research
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
Keywords
ferroportin, sickle cell trait, anemia, malaria, bacteremia, iron acquisition, selection pressure
MeSH terms
Iron Deficiencies, Ferroportin, Anemia, Erythrocytes, Female, Humans, Infant, Infant, Newborn, Iron, Malaria, Male, Bacteremia, Amino Acid Substitution, Mutation, Missense, Cation Transport Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The ferroportin Q248H mutation protects from anemia, but not malaria or bacteremia. https://app.cochat.ai/papers/10.1126/sciadv.aaw0109
The paper
Muriuki, J. M., Mentzer, A. J., Band, G., Gilchrist, J. J., Carstensen, T., Lule, S. A., Goheen, M. M., Joof, F., Kimita, W., Mogire, R., Cutland, C. L., Diarra, A., Rautanen, A., Pomilla, C., Gurdasani, D., Rockett, K., Mturi, N., Ndungu, F. M., Scott, J. A. G., . . . Atkinson, S. H. (2019). The ferroportin Q248H mutation protects from anemia, but not malaria or bacteremia. Science Advances. https://doi.org/10.1126/sciadv.aaw0109

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.